124 related articles for article (PubMed ID: 23356633)
1. Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA.
Smith J; Nazare JA; Borel AL; Aschner P; Barter PJ; Van Gaal L; Matsuzawa Y; Kadowaki T; Ross R; Brulle-Wohlhueter C; Alméras N; Haffner SM; Balkau B; Després JP
Diabetes Obes Metab; 2013 Jul; 15(7):629-41. PubMed ID: 23356633
[TBL] [Abstract][Full Text] [Related]
2. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study.
Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study).
Nazare JA; Smith J; Borel AL; Aschner P; Barter P; Van Gaal L; Tan CE; Wittchen HU; Matsuzawa Y; Kadowaki T; Ross R; Brulle-Wohlhueter C; Alméras N; Haffner SM; Balkau B; Després JP;
Am J Cardiol; 2015 Feb; 115(3):307-15. PubMed ID: 25499404
[TBL] [Abstract][Full Text] [Related]
4. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity.
Nazare JA; Smith JD; Borel AL; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
Am J Clin Nutr; 2012 Oct; 96(4):714-26. PubMed ID: 22932278
[TBL] [Abstract][Full Text] [Related]
5. Associations between breast adipose tissue, body fat distribution and cardiometabolic risk in women: cross-sectional data and weight-loss intervention.
Schautz B; Later W; Heller M; Müller MJ; Bosy-Westphal A
Eur J Clin Nutr; 2011 Jul; 65(7):784-90. PubMed ID: 21427743
[TBL] [Abstract][Full Text] [Related]
6. Abdominal visceral fat measurement using dual-energy X-ray: association with cardiometabolic risk factors.
Rothney MP; Catapano AL; Xia J; Wacker WK; Tidone C; Grigore L; Xia Y; Ergun DL
Obesity (Silver Spring); 2013 Sep; 21(9):1798-802. PubMed ID: 23696250
[TBL] [Abstract][Full Text] [Related]
7. Associations of the limb fat to trunk fat ratio with markers of cardiometabolic risk in elderly men and women.
Saunders TJ; Davidson LE; Janiszewski PM; Després JP; Hudson R; Ross R
J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1066-70. PubMed ID: 19561143
[TBL] [Abstract][Full Text] [Related]
8. Visceral adipose tissue and body fat mass: predictive values for and role of gender in cardiometabolic risk among Turks.
Onat A; Uğur M; Can G; Yüksel H; Hergenç G
Nutrition; 2010 Apr; 26(4):382-9. PubMed ID: 19632090
[TBL] [Abstract][Full Text] [Related]
9. Contributions of cardiorespiratory fitness and visceral adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women.
Rhéaume C; Arsenault BJ; Dumas MP; Pérusse L; Tremblay A; Bouchard C; Poirier P; Després JP
J Clin Endocrinol Metab; 2011 May; 96(5):1462-8. PubMed ID: 21325457
[TBL] [Abstract][Full Text] [Related]
10. Cardiac steatosis associates with visceral obesity in nondiabetic obese men.
Granér M; Siren R; Nyman K; Lundbom J; Hakkarainen A; Pentikäinen MO; Lauerma K; Lundbom N; Adiels M; Nieminen MS; Taskinen MR
J Clin Endocrinol Metab; 2013 Mar; 98(3):1189-97. PubMed ID: 23418318
[TBL] [Abstract][Full Text] [Related]
11. Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity.
Rauzier C; Chartrand DJ; Alméras N; Lemieux I; Larose E; Mathieu P; Pibarot P; Lamarche B; Rhéaume C; Poirier P; Després JP; Picard F
Front Endocrinol (Lausanne); 2023; 14():1222101. PubMed ID: 37854178
[TBL] [Abstract][Full Text] [Related]
12. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention.
Thamer C; Machann J; Stefan N; Haap M; Schäfer S; Brenner S; Kantartzis K; Claussen C; Schick F; Haring H; Fritsche A
Obesity (Silver Spring); 2007 Feb; 15(2):531-8. PubMed ID: 17299127
[TBL] [Abstract][Full Text] [Related]
13. Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study.
Kim LJ; Nalls MA; Eiriksdottir G; Sigurdsson S; Launer LJ; Koster A; Chaves PH; Jonsdottir B; Garcia M; Gudnason V; Harris TB;
Obesity (Silver Spring); 2011 Jun; 19(6):1265-71. PubMed ID: 21183935
[TBL] [Abstract][Full Text] [Related]
14. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
15. Breast volume is an independent predictor of visceral and ectopic fat in premenopausal women.
Janiszewski PM; Saunders TJ; Ross R
Obesity (Silver Spring); 2010 Jun; 18(6):1183-7. PubMed ID: 19851312
[TBL] [Abstract][Full Text] [Related]
16. Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial).
Meyers CD; McCarren M; Wong ND; Abraira C; Duckworth WC; Kashyap ML;
Am J Cardiol; 2006 Jul; 98(1):63-5. PubMed ID: 16784922
[TBL] [Abstract][Full Text] [Related]
17. Predictors of ectopic fat accumulation in liver and pancreas in obese men and women.
Rossi AP; Fantin F; Zamboni GA; Mazzali G; Rinaldi CA; Del Giglio M; Di Francesco V; Barillari M; Pozzi Mucelli R; Zamboni M
Obesity (Silver Spring); 2011 Sep; 19(9):1747-54. PubMed ID: 21593811
[TBL] [Abstract][Full Text] [Related]
18. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity.
Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Metabolism; 2012 Feb; 61(2):262-72. PubMed ID: 21864868
[TBL] [Abstract][Full Text] [Related]
19. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Obesity (Silver Spring); 2012 Jun; 20(6):1223-33. PubMed ID: 22262155
[TBL] [Abstract][Full Text] [Related]
20. Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors.
Yi W; Kim K; Im M; Ryang S; Kim EH; Kim M; Jeon YK; Kim SS; Kim BH; Pak K; Kim IJ; Kim SJ
Sci Rep; 2022 Jan; 12(1):387. PubMed ID: 35013484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
